Related Experiment Video
Updated: Jun 2, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Imaging of mesothelioma
1Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA. rgill@partners.org
Summary
Malignant pleural mesothelioma (MPM), an asbestos-related cancer, requires advanced imaging for diagnosis and management. This review details how CT, MRI, and PET/CT scans aid in staging and treatment monitoring for this aggressive neoplasm.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Malignant pleural mesothelioma (MPM) is a rare but aggressive cancer linked to asbestos exposure.
- It originates in the pleura, progressively encasing the lungs and mediastinum.
- Accurate diagnosis and staging are critical for effective patient management.
Purpose of the Study:
- To review the critical role of various imaging modalities in the diagnosis and management of MPM.
- To highlight the strengths and weaknesses of different imaging techniques for MPM.
- To guide the use of imaging in staging and monitoring treatment response.
Main Methods:
- Computed Tomography (CT) as the primary initial imaging modality.
- Magnetic Resonance Imaging (MRI) for detailed assessment of chest wall and diaphragmatic invasion.
- FDG-PET/CT for integrated anatomical and metabolic staging and therapy response monitoring.
Main Results:
- CT is essential for initial MPM detection and assessment.
- MRI offers superior soft tissue contrast for evaluating local invasion.
- FDG-PET/CT provides comprehensive staging and is valuable for tracking treatment efficacy.
Conclusions:
- A multi-modal imaging approach is crucial for optimal MPM management.
- Imaging guides therapeutic decisions and assesses treatment effectiveness.
- Understanding imaging findings is key to improving outcomes for patients with MPM.
